Provided by Tiger Trade Technology Pte. Ltd.

InflaRx N.V.

2.10
+0.08003.96%
Post-market: 2.06-0.0382-1.82%18:31 EDT
Volume:419.89K
Turnover:873.38K
Market Cap:309.32M
PE:-3.67
High:2.12
Open:2.03
Low:2.03
Close:2.02
52wk High:2.95
52wk Low:0.7984
Shares:147.29M
Float Shares:106.00M
Volume Ratio:0.51
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5715
EPS(LYR):-0.7963
ROE:-38.52%
ROA:-18.54%
PB:1.81
PE(LYR):-2.64

Loading ...

InflaRx to Present at H.C. Wainwright Annual Global Investment Conference

Reuters
·
Aug 20

InflaRx Price Target Raised to $6.00/Share from $4.00 by Cantor Fitzgerald

Dow Jones
·
Aug 07

Analysts’ Top Healthcare Picks: InflaRx (IFRX), CG Oncology, Inc. (CGON)

TIPRANKS
·
Aug 07

InflaRx NV Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

InflaRx Posts H1 Loss as Warrant Fair-Value Hit Outweighs FX Gains, R&D Spending Falls

Reuters
·
Aug 06

InflaRx H1 FY26 Net Loss Narrows to €16.2 Million

Reuters
·
Aug 06

InflaRx Q2 EPS $(0.10) Misses $(0.08) Estimate

Benzinga Earnings
·
Aug 06

Press Release: InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Dow Jones
·
Aug 06

InflaRx NV Expected to Post a Loss of 6 Cents a Share - Earnings Preview

Reuters
·
Aug 04

InflaRx to Report Second-quarter Results Before Market Open

Reuters
·
Jul 30

Analysts Offer Insights on Healthcare Companies: InflaRx (IFRX) and Baxter International (BAX)

TIPRANKS
·
Jul 27

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 21

InflaRx (IFRX) Gets a Buy from Oppenheimer

TIPRANKS
·
Jun 30

Inflarx Weighs Broader Europe AAV Strategy, Plans EMA Talks on Vilobelimab and Izicopan

Reuters
·
Jun 30

Palisade Bio adds Robert Baltera, Jordan Zwick to board of directors

Reuters
·
Jun 11

InflaRx price target raised to $8 from $6 at H.C. Wainwright

TIPRANKS
·
May 12

InflaRx Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 12

InflaRx Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
May 11

InflaRx closes USD 150 million follow-on offering of 75,000,000 shares at USD 2 each

Reuters
·
May 08

Press Release: InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares

Dow Jones
·
May 08